Chinook Therapeutics Inc (KDNY) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Chinook Therapeutics Inc   (NASDAQ: KDNY)


Chinook Therapeutics Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Chinook Therapeutics Inc's ROI in the second quarter of 2023?
Chinook Therapeutics Inc recorded a cumulative net loss of $-246 million during 12 months ending in the second quarter of 2023, resulting in a negative return on investment (ROI) of -49.18%.

Within the Healthcare sector 585 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2023 from 3922 to 4275.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM 2.47 % 21.07 % 30.1 % 40.16 % 51.23 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 436 493 523 546 572
Return On Investment (TTM) -49.18 % -40.56 % -35.19 % -22.06 % -18.97 %
KDNY's Overall Ranking # 4275 # 3922 # 3724 # 0 # 0
Seq. Investment Change TTM -6.35 % -0.08 % -0.02 % 9.53 % 10.65 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -246 -216 -188 -118 -92

KDNY Company Profile >> Back to KDNY Roi Comparisons >> See Annual KDNY Return On Investment



Return On Investment KDNY's Ranking
Within: No.
Industry # 243
Sector # 586
Overall # 4275

Return On Investment Statistics
High Average Low
-5.28 %
-25.35 %
-46.11 %
(Jun 30 2016)   (Jun 30 2023)







Financial Statements
Chinook Therapeutics Inc's II. Quarter Investments $ 436 Millions KDNY's Balance sheet
Chinook Therapeutics Inc's II. Quarter Income $ -67 Millions Quarterly KDNY's Income Statement
KDNY's Income by Division See KDNY's Income by Division


KDNY Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 523 524 406 71 154
Y / Y Investment Growth -0.09 % 28.93 % 471.19 % -53.92 % -61.78 %
Net Income in Millions -188 -103 -82 -82 -95
Y / Y Net Income Growth - - - - -
Annual Return On Investment -35.9 % -19.66 % -20.09 % -115.83 % -61.79 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KDNY's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KDNY's Competitors
Subscribers only: Roi for Chinook Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for KDNY's Customers

Other Ratios
KDNY's Roa KDNY's Inventory Turnover Ratio KDNY's Growth Rates KDNY's Dividend Statistics
KDNY's Profitability Ratios KDNY's Asset Turnover Ratio KDNY's Dividend Growth
KDNY's Roe KDNY's Valuation Ratios KDNY's Financial Strength Ratios KDNY's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.